"Dr. Sepe Sehati, Chief Scientific and Regulatory Affairs Lead at Love Hemp, says "It's been a huge pleasure to spend the past few months leading a dedicated team to compile a robust evidence-based dossier for submission to the FSA. To my knowledge, Love Hemp's application is also in the unique position of having provided comprehensive pre-clinical results, based on our own proprietary study protocols, investigating the effects of Love Hemp's finished product formulations on the pharmacokinetics of CBD. To have been able to do this at pre-validation stage is a great achievement."
Just started to get onto people's radar. Name change to come in a week to LoveHemp, revenues over £2m and still a paltry mcap. Wake up and smell the coffee here, this will make ZOE rise look like small fry.
Tony Calamita is now the CEO of LIFE. This is his baby for sure and this is a great appointment. He will steer this ship now. Consideration all sorted now and he has lots of skin in the game. Recent interview sounds like newsflow to ram up here. This is the going to be ZOE but on a much larger scale.
Accumulate and hold for a few years and it will make you smile!
You not see what ORR did in the last week JoeStrummer MickJones? It went from 0.5 to 1.75 in about four sessions mainly because it was undervalued. Now I'm new to RMM but I feel the same trading feel here. Lots of volume today and a nice rise into finish. I'm expecting a bag by end of the week. Sentiment can change very quickly especially after a couple of days on the risers board....
Absolutely not. Senala will be sold for a premium. This is the start of a rerate. Look at Chesser resources next to Senala, mcap recently treated to $100m. We have bigger area and are working with IAMGOLD. They will bid for Senala, it is a patience game. ORR not a one trick pony. Cameroon and Djibouti too. Rig mobbed in Cameroon ready for a double drill.
"The Warrants will have an exercise price of 0.68 pence per share and an expiration date of 24 months from the date of the issue of the Placing Shares or the Offer Shares. The Warrants will also be subject to an accelerator provision, such that if at any time during the 24 month duration of the Warrants the 10 day volume-weighted average price (VWAP) of Oriole ordinary shares exceeds 1.02 pence per share, the Company may give Warrant holders notice to exercise their Warrants within 10 business days following the Company's notice and to pay the exercise price in full within 15 business days following the Company's notice, failing which the Warrants will automatically expire."